Intelligence · Clinical Development
Pipeline search results
Programs matching “nab-paclitaxel” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 15 pipeline programs matching "nab-paclitaxel" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
B013+Nab-Paclitaxel
BRIGHT MINDS BIOSCIENCES INC.
Triple Negative Breast Cancer (TNBC)
1 trial -
Nab-paclitaxel 80 mg/m^2
CORCEPT THERAPEUTICS INC
Ovarian Neoplasm
1 trial -
nab-paclitaxel combined with carboplatin
The First People's Hospital of Lianyungang
Epithelial Ovarian Carcinoma Stage III
1 trial -
AK112-210
Akeso
Metastatic Pancreatic Ductal Adenocarcinoma
1 trial -
L2023-K003-002
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
Nab paclitaxel
BRIGHT MINDS BIOSCIENCES INC.
Metastatic Pancreatic Cancer
1 trial -
Nab-paclitaxel
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Head and Neck Squamous Cell Carcinoma
1 trial -
Nab-paclitaxel Combined With Cadonilimab (AK104)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Cancer
1 trial -
Relacorilant with nab-paclitaxel
CORCEPT THERAPEUTICS INC
Solid Tumors
1 trial -
Sintilimab,nab-paclitaxel and tegio
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
anlotinib+TQB2450+nab-paclitaxel+cisplatin
The First People's Hospital of Lianyungang
Advanced Biliary Tract Cancer
1 trial -
nab-paclitaxel
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Fostamatinib in combination with chemotherapy (gemcitabine and nab-paclitaxel)
RIGEL PHARMACEUTICALS INC
Pancreatic Ductal Adenocarcinoma (PDAC)
1 trial -
OMP-54F28, Nab-Paclitaxel and Gemcitabine
Mereo BioPharma Group plc
Pancreatic Cancer
1 trial -
Nab-paclitaxel
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.